Excel venture

Excel Venture Management, founded in 2007 and headquartered in Boston, Massachusetts, specializes in investing in transformative life science technologies. The firm’s portfolio spans healthcare IT, diagnostics, medical devices, and life science platforms, addressing a broad array of industries including agriculture, energy, and defense. Notable investments include InfoBionic, Aileron Therapeutics, and Molecular Templates. Excel's strategy focuses on early to late-stage investments, typically ranging from $1 million to $5 million. They avoid single-molecule drugs, preferring platform technologies that offer multiple exit scenarios and applications across diverse market sectors. The firm's holistic approach involves extensive due diligence, strategic guidance, and leveraging a global network of resources to drive portfolio companies towards leadership positions in their fields. The team, led by key figures like Jeanne Henry (CFO) and Juan Enriquez (Managing Director), brings a wealth of experience in venture capital, financial management, and life sciences. They work closely with entrepreneurs to refine corporate strategies, develop value-driven milestones, and facilitate customer and partner introductions, ultimately aiming for successful exits through acquisitions or IPOs. Excel Venture Management has been instrumental in the success of companies like ClearDATA, Cleveland HeartLab, and Synthetic Genomics, showcasing their commitment to driving innovation in the life sciences sector and beyond​.